Oxford Live 2022

Published: 20 September 2022

  • Views:

    Views Icon 2425
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Now in its twelfth year, Oxford Live 2022, held on 1 September, was a case-based meeting combining coronary and structural live case transmissions from John Radcliffe Hospital, Oxford, with lecture presentations from national and international faculty. 

 

The conference was led by course director and consultant cardiologist Prof Adrian Banning (John Radcliffe Hospital, UK).

 

This on-demand version of the programme is aimed at cardiologists, cardiac surgeons, specialist registrars and allied health professionals involved in caring for cardiac patients. 

Oxford Live 2022 is supported by Boston Scientific.

Key Learning Objectives

  • To understand the management of coronary disease in patients with aortic stenosis
  • To understand the role of imaging in pre and post assessment of coronary disease and its management
  • To understand the influence of calcium on outcomes of coronary intervention and how to optimise patient outcomes

Target Audience

  • Cardiologists
  • Cardiac surgeons
  • Specialist registrars
  • Allied health professionals involved in caring for cardiac patients

More from this programme

Faculty Biographies

Giovanni Luigi De Maria

Giovanni Luigi De Maria

Consultant Cardiologist

Dr Giovanni Luigi De Maria is a Consultant Cardiologist at John Radcliffe Hospital in Oxford. He is an interventional cardiologist and has worked in the Oxford University Hospitals NHS Foundation trust for close to 7 years.

Dr Luigi De Maria graduated from the Catholic University of the Sacred Heart in Rome in 2008 and completed his training in General Cardiology at Policlinico A Gemelli in Rome in 2014. He worked at Oxford University Hospitals as a Clinical Fellow in Interventional Cardiology from 2014 until 2018, when he became a consultant. In 2019 he completed his PhD in 'Clinical, Cellular and Molecular Research'.

His main research interests are predicting outcome in patients with STEMI, coronary physiology and intravascular imaging. He is involved in a number of randomised clinical trials including (SYNTAX II, NOBLE, EBC- Main, FAME 3, ERIC PPCI).

View full profile